Mainland China
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
Global Times: Mogao Caves' mural paintings meet modern technology
BEIJING, Dec. 7, 2025 /PRNewswire/ -- The flying Apsaras dance across the heavens; caravan bells echo along ancient routes. Dunhuang, a pivotal hub on the ancient Silk Road, served as a crossroads where diverse civilizations converged, giving birth to the radiant splendor of the Mogao Caves. As a...
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced today announced with great pleasure that its independently developed fully human BCMA-targeted CAR-T product, zevorcabtage...
All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
HONG KONG, Dec. 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL) for 2025, released byChina's National Healthcare Securi...
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 6, 2025 /PRNewswire/ -- Vivacta Bio, a spin-off company of Grit Biotherapeutics advancing in vivo CAR-T therapies for oncology and autoimmune diseases, today announced encouraging initial data from an investigator-initiated, first-in-human study of GT801, a T-LNP/mRNA–based in viv...
China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier inChina, today announced that its subsidiary, Hyoseong ( Wuhan) Motion Mechatronics System Co. Ltd., has entered the final co...
AliExpress and Specialized Partner with Law Enforcement in largest Counterfeit Bust in Brand's History
– Two Operations Dismantled, Over $1,600,000 in Counterfeit Goods Seized – HANGZHOU, China, Dec. 5, 2025 /PRNewswire/ -- AliExpress, the leading global e-commerce marketplace, in collaboration with premium American bicycle brand Specialized and Chinese law enforcement, recently played a central r...
Prof. Gang Shen's Research Paper about Mandibular Advancement Repositioning Technology in the Journal of Aligner Orthodontics
SHANGHAI, Dec. 5, 2025 /PRNewswire/ -- A clinical study developed by Professor Gang Shen's Orthodontic Team from Taikang Bybo Dental has been officially published in the Journal of Aligner Orthodontics (JAO). The article presents key findings on the use of Mandibular Advancement Repositioning The...
Tuniu Announces Unaudited Third Quarter 2025 Financial Results
NANJING, China, Dec. 5, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced its unaudited financial results for the third quarter ended September 30, 2025. "In the third quarter, our business maintained...
'Keywords to Understand China' new series facilitates cultural understanding
BEIJING, Dec. 5, 2025 /PRNewswire/ -- This is a report from China.org.cn:   Keywords to understand China: Common values of humanity The multilingual book series "Keywords to Understand China: Global Civilization Initiative," the latest of the "Keywords to Understand China" p...
TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet
NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 /PRNewswire/ -- TransThera Sciences Inc. ("TransThera") announced the publication of clinical results from a US-based Phase 2 trial evaluating tinengotinib in patients with Cholangiocarcinoma (CCA) on The Lancet Gastroenterology and Hepatology (I...
Blueprint to offer new opportunity
China's 15th Five-Year Plan set to bring about fresh momentum for global growth
BEIJING, Dec. 4, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn:
Xinhua Silk Road: A bowl of Changle gangmian noodles comforts homesickness thousands of miles away
BEIJING, Dec. 4, 2025 /PRNewswire/ -- The 3rd Overseas Chinese Talent
Conference for Development was held inFuzhou, capital city of southeast China's
Fujian Province on December 1-3, with overseas Chinese of Fujian origin from 39
countries and regions gathering by the Minjiang River.
OTR Therapeutics Raises $100 Million in Series A Financing to Advance Early Innovation into Global Transformative Therapies
SHANGHAI, Dec. 4, 2025 /PRNewswire/ -- OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, emerged from stealth and announced today the successful completion of a$100 million Series A financing closed in June 2025. The rou...
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
SAN FRANCISCO and SUZHOU, China, Dec. 4, 2025 /PRNewswire/ -- Innovent Biologics (HKEX: 01801) today announced that the global strategic collaboration with Takeda (TSE: 4502, NYSE: TAK) has closed and become effective following the satisfaction of all closing conditions. The collaboration, initia...
PINTEC TO HOLD EXTRAORDINARY GENERAL MEETING ON JANUARY 8, 2026
BEIJING, Dec. 4, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (NASDAQ: PT) ("Pintec" or the "Company"), a technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that the Company will hold its extraordinary general ...
WiMi Studies Hybrid Quantum-Classical Learning Architecture for Multi-Class Image Classification
BEIJING, Dec. 4, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), is a leading global Hologram Augmented Reality ("AR") Technology provider. On the basis of in-depth research on quantum convolutional neural networks (QCNN), it proposed a new type of hybrid ...
300MW/1200MWh Energy Storage Station Successfully Commissioned -- Powered by SINEXCEL's 1725kW PCS
SHENZHEN, China, Dec. 4, 2025 /PRNewswire/ -- The first phase (300 MW/1200 MWh) ofChina's largest electrochemical energy storage station, powered by SINEXCEL's 1725kW utility-scale Power Conversion System (PCS), has been successfully commissioned. This milestone marks a critical step toward full-...
Week's Top Stories
Most Reposted
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 311 media titles]
2026-02-26 09:30Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 309 media titles]
2026-02-26 19:57Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 309 media titles]
2026-03-04 12:35SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
[Picked up by 290 media titles]
2026-03-02 09:00